🇺🇸 FDA

Company profile · Sponsor

Oncotelic

Oncotelic Therapeutics

OTLC · NYSE pharma AGUORA HILLS, CA, USA
Pipeline
4
Drugs
0
Patents
1

Quick answer

Oncotelic (OTLC) is a pharma company. headquartered in AGUORA HILLS, CA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker OTLC
Exchange NYSE
Company type pharma
Headquarters AGUORA HILLS, CA, USA
SEC CIK 0000908259

Pipeline (4)

Search pipeline →

  1. OT-101

    Oncotelic

    Pancreatic Ductal Adenocarcinoma

    phase 3 small molecule active

    1 trial

  2. Atezolizumab

    Oncotelic

    Metastatic Lung Non-Small Cell Carcinoma

    phase 2 mab terminated

    1 trial

  3. OT-101

    Oncotelic

    COVID-19

    phase 2 small molecule active

    1 trial

  4. OT-101

    Oncotelic

    Malignant Pleural Mesothelioma

    phase 2 small molecule active

    1 trial

Patents (1)

Search patents →

  1. US 11419934

    Use of VDAS to enhance immunomodulating therapies against tumors

    Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Oncotelic?

Oncotelic (OTLC) is a pharma company. headquartered in AGUORA HILLS, CA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does Oncotelic sponsor?

We track 4 ClinicalTrials.gov-linked programs for Oncotelic, including OT-101 and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Oncotelic company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.